Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinomaWeijing Sun, Kim M. Olthoff, Mark Rosen et al.|Cancer|2011Cited by 97
A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinomaDavendra Sohal, Weijing Sun, Kristine Mykulowycz et al.|Annals of Oncology|2013Cited by 89